piperidine has been researched along with Schizophrenia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Gao, L; Hu, J; Huang, L; Song, T; Yin, L; Zhang, X | 1 |
de Sá, MM; Magalhães, JG; Maltarollo, VG; Primi, MC; Rangel-Yagui, CO; Trossini, GH | 1 |
Arora, J; Balestra, M; Breysse, N; Brockel, B; Brown, DG; Brugel, TA; Brush, KA; Chhajlani, V; Gadient, RA; Hightower, C; Hinkley, L; Hoesch, V; Isaac, M; Kang, J; King, MM; Koether, GM; McCauley, JP; McLaren, FM; Panko, LM; Simpson, TR; Slassi, A; Smith, RW; Spear, N; Sygowski, LA; Wilson, JM; Woods, JM; Xiong, H; Zhang, M | 1 |
Aimone, LD; Angeles, T; Bacon, ER; Bailey, TR; Brown, R; Connors, T; Dicamillo, A; Dunn, DD; Duzic, E; Galinis, D; Holskin, B; Huffman, MJ; Kopec, K; Lu, LD; Mathiasen, JR; McKenna, BA; Morton, GC; Qian, J; Rosse, GC; Salvino, JM; Schaffhauser, H; Spais, C; Sundar, BG; Zeqi, H | 1 |
4 other study(ies) available for piperidine and Schizophrenia
Article | Year |
---|---|
Synthesis and pharmacological evaluation of piperidine (piperazine)-amide substituted derivatives as multi-target antipsychotics.
Topics: Amides; Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Humans; Ligands; Molecular Structure; Piperazine; Piperidines; Rats; Receptors, Dopamine D2; Receptors, Serotonin; Schizophrenia; Structure-Activity Relationship | 2020 |
Convergent QSAR studies on a series of NK₃ receptor antagonists for schizophrenia treatment.
Topics: Cyclopropanes; Humans; Piperidines; Quantitative Structure-Activity Relationship; Receptors, Neurokinin-3; Schizophrenia | 2016 |
4-aryl piperazine and piperidine amides as novel mGluR5 positive allosteric modulators.
Topics: Allosteric Regulation; Amides; Humans; Microsomes, Liver; Piperazine; Piperazines; Piperidines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Schizophrenia; Structure-Activity Relationship | 2010 |
Novel brain penetrant benzofuropiperidine 5-HT₆ receptor antagonists.
Topics: Animals; Benzofurans; Brain; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Inhibitory Concentration 50; Kinetics; Memory, Short-Term; Models, Chemical; Piperidines; Rats; Receptors, Serotonin; Schizophrenia; Serotonin Antagonists; Structure-Activity Relationship | 2012 |